Medical Condition News

RSS

Scientists uncover promising therapeutic target for autoimmune disease affecting the brain

Scientists have identified a promising target for treatment of a devasting autoimmune disease affecting the brain.

14 Jan 2026

Study reveals genetic signatures linked to HIV-related cognitive impairment

Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures associated with HIV infection that may contribute to the cognitive impairment that often occurs in people living with HIV, even when the virus is controlled.

14 Jan 2026

Rare immune events link Epstein Barr virus to early multiple sclerosis damage

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself.

14 Jan 2026

Bradycardia emerges as key clinical sign of xylazine-opioid overdose

Researchers have identified bradycardia-an abnormally low heart rate–as a symptom of xylazine-opioid overdose.

14 Jan 2026

CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatment

Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism. Transthyretin amyloidosis (ATTR) is a progressive disorder involving amyloid deposits of misfolded transthyretin (TTR) proteins.

14 Jan 2026

Novel liquid biopsy technology could advance cancer diagnostics and monitoring

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow.

14 Jan 2026

Heart failure care gaps found among Asian American ethnic groups

Using nearly a decade of data (2015–2023) from 800+ U.S. hospitals and more than 700,000 patients overall, Northwestern researchers found that when Asian American heart failure patients are separated by ethnicity, rather than grouped together as "Asian," important differences in care emerge across groups including Filipino, Vietnamese, Chinese, Asian Indian, Korean and Japanese patients.

14 Jan 2026

HIF1 protein identified as key driver of tendon pain

Overuse of our tendons can cause painful medical conditions for which only limited treatment options exist. Researchers have now deciphered an important molecular mechanism that triggers these problems.

14 Jan 2026

Post-meal blood sugar spikes linked to increased Alzheimer's risk

A new study led by researchers from the University of Liverpool has found that spikes in blood sugar after meals may increase the risk of Alzheimer's disease.

14 Jan 2026

Disease-responsive nanoparticles enable ghrelin mRNA therapy in osteoarthritis

Nitin Joshi, PhD, and Jingjing Gao, PhD, of the Department of Anesthesiology at Mass General Brigham, are the co-senior authors of a paper published in Nature Nanotechnology, "A disease-severity-responsive nanoparticle enables potent ghrelin mRNA therapy in osteoarthritis." Mahima Dewani, PhD, is the lead author of this study.

14 Jan 2026

RAS-MAPK inhibition halts spinal deformity in neurofibromatosis type 1 mouse model

Spinal deformities such as scoliosis and kyphosis are among the most serious complications of neurofibromatosis type 1 (NF1), a genetic disorder that affects about one in 3,000 people.

14 Jan 2026

Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study

A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a new study by researchers at Umeå University, Sweden.

14 Jan 2026

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly approved immunotherapy called tarlatamab.

14 Jan 2026

New BIND screener identifies brain-related comorbidities risk in Duchenne muscular dystrophy

In research published in Developmental Medicine & Child Neurology, investigators developed a brief, reliable, and valid screening tool to help identify individuals with Duchenne muscular dystrophy (a neuromuscular disorder) who are at increased risk of brain-related comorbidities, such as language disorders, attention-deficit/hyperactivity disorder, and anxiety.

14 Jan 2026

Long-term singles experience sharper decline in life satisfaction and well-being

More and more young adults abstain from entering committed romantic relationships, and this may be affecting their well-being.

14 Jan 2026

Silent thief of sight: Rutgers Health experts highlight glaucoma risks, early detection

January is Glaucoma Awareness Month, prompting Rutgers Health experts to underscore the importance of early detection and public awareness.

14 Jan 2026

Cannabidiol could become a therapeutic tool for fetal alcohol spectrum disorder

Cannabidiol (CBD) could become a therapeutic tool to address some of the most frequent and disabling consequences of fetal alcohol spectrum disorder (FASD), a condition caused by alcohol exposure during pregnancy.

14 Jan 2026

DTU researchers discover gut bacteria link to reduced allergy and asthma risk

Researchers from DTU have patented an invention that uses naturally produced substances from gut bacteria of the bifidobacteria type to reduce the risk of allergies and asthma.

14 Jan 2026

New metabolomic signature predicts type 2 diabetes risk beyond traditional factors

Diabetes, a metabolic disease, is on the rise worldwide, and over 90 percent of cases are type 2 diabetes, where the body does not effectively respond to insulin.

14 Jan 2026

Vaccines are helping older people more than we knew

Let's be clear: The primary reason to be vaccinated against shingles is that two shots provide at least 90% protection against a painful, blistering disease that a third of Americans will suffer in their lifetimes, one that can cause lingering nerve pain and other nasty long-term consequences.

14 Jan 2026

1
2
3
4
...
5815
Next

Medical Condition News

Scientists uncover promising therapeutic target for autoimmune disease affecting the brain

Study reveals genetic signatures linked to HIV-related cognitive impairment

Rare immune events link Epstein Barr virus to early multiple sclerosis damage

Bradycardia emerges as key clinical sign of xylazine-opioid overdose

CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatment

Novel liquid biopsy technology could advance cancer diagnostics and monitoring

Heart failure care gaps found among Asian American ethnic groups

HIF1 protein identified as key driver of tendon pain

Post-meal blood sugar spikes linked to increased Alzheimer's risk

Disease-responsive nanoparticles enable ghrelin mRNA therapy in osteoarthritis

RAS-MAPK inhibition halts spinal deformity in neurofibromatosis type 1 mouse model

Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

New BIND screener identifies brain-related comorbidities risk in Duchenne muscular dystrophy

Long-term singles experience sharper decline in life satisfaction and well-being

Silent thief of sight: Rutgers Health experts highlight glaucoma risks, early detection

Cannabidiol could become a therapeutic tool for fetal alcohol spectrum disorder

DTU researchers discover gut bacteria link to reduced allergy and asthma risk

New metabolomic signature predicts type 2 diabetes risk beyond traditional factors

Vaccines are helping older people more than we knew

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News